SG11202008102VA - Cyclopentane-based modulators of sting (stimulator of interferon genes) - Google Patents
Cyclopentane-based modulators of sting (stimulator of interferon genes)Info
- Publication number
- SG11202008102VA SG11202008102VA SG11202008102VA SG11202008102VA SG11202008102VA SG 11202008102V A SG11202008102V A SG 11202008102VA SG 11202008102V A SG11202008102V A SG 11202008102VA SG 11202008102V A SG11202008102V A SG 11202008102VA SG 11202008102V A SG11202008102V A SG 11202008102VA
- Authority
- SG
- Singapore
- Prior art keywords
- sting
- stimulator
- cyclopentane
- interferon genes
- based modulators
- Prior art date
Links
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 title 2
- 101000643024 Homo sapiens Stimulator of interferon genes protein Proteins 0.000 title 1
- 102100035533 Stimulator of interferon genes protein Human genes 0.000 title 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
- C07F9/65744—Esters of oxyacids of phosphorus condensed with carbocyclic or heterocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H19/213—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids containing cyclic phosphate
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862643467P | 2018-03-15 | 2018-03-15 | |
| US201862666204P | 2018-05-03 | 2018-05-03 | |
| US201862742532P | 2018-10-08 | 2018-10-08 | |
| US201962809990P | 2019-02-25 | 2019-02-25 | |
| PCT/IB2019/052009 WO2019175776A1 (en) | 2018-03-15 | 2019-03-12 | Cyclopentane-based modulators of sting (stimulator of interferon genes) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202008102VA true SG11202008102VA (en) | 2020-09-29 |
Family
ID=66103038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202008102VA SG11202008102VA (en) | 2018-03-15 | 2019-03-12 | Cyclopentane-based modulators of sting (stimulator of interferon genes) |
Country Status (24)
| Country | Link |
|---|---|
| US (4) | US10538542B2 (en) |
| EP (1) | EP3765474B1 (en) |
| JP (1) | JP7266942B2 (en) |
| KR (1) | KR20200131878A (en) |
| CN (1) | CN111918871A (en) |
| AU (1) | AU2019234043A1 (en) |
| BR (1) | BR112020018593A2 (en) |
| CA (1) | CA3093631C (en) |
| CL (1) | CL2020002352A1 (en) |
| CR (1) | CR20200382A (en) |
| DO (1) | DOP2020000160A (en) |
| EC (1) | ECSP20057847A (en) |
| ES (1) | ES2923298T3 (en) |
| IL (1) | IL277278A (en) |
| MA (1) | MA52012A (en) |
| MX (1) | MX2020009587A (en) |
| NI (1) | NI202000058A (en) |
| PE (1) | PE20210412A1 (en) |
| PH (1) | PH12020551486A1 (en) |
| RU (1) | RU2020130048A (en) |
| SG (1) | SG11202008102VA (en) |
| TW (1) | TWI741268B (en) |
| UY (1) | UY38145A (en) |
| WO (1) | WO2019175776A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111566120B (en) | 2017-12-20 | 2023-09-29 | 捷克共和国有机化学与生物化学研究所 | 3' cyclic dinucleotides with phosphonate bonds of activated STING adaptor protein |
| US11203610B2 (en) | 2017-12-20 | 2021-12-21 | Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. | 2′3′ cyclic dinucleotides with phosphonate bond activating the sting adaptor protein |
| KR20200140867A (en) | 2018-04-06 | 2020-12-16 | 인스티튜트 오브 오가닉 케미스트리 앤드 바이오케미스트리 에이에스 씨알 브이.브이.아이. | 3'3'-cyclic dinucleotide |
| TW202028179A (en) | 2018-10-08 | 2020-08-01 | 美商普萊恩醫療公司 | Amino acid compounds and methods of use |
| CN114728946A (en) * | 2019-09-25 | 2022-07-08 | 辉瑞公司 | Polyheterocyclic modulators of STING (stimulator of interferon genes) |
| WO2021206158A1 (en) | 2020-04-10 | 2021-10-14 | 小野薬品工業株式会社 | Method of cancer therapy |
| US11964978B2 (en) * | 2021-03-18 | 2024-04-23 | Pfizer Inc. | Modulators of STING (stimulator of interferon genes) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR0166088B1 (en) | 1990-01-23 | 1999-01-15 | . | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| AU2015270640B2 (en) * | 2014-06-04 | 2017-10-26 | Glaxosmithkline Intellectual Property Development Limited | Cyclic di-nucleotides as modulators of STING |
| GB201501462D0 (en) * | 2015-01-29 | 2015-03-18 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
-
2019
- 2019-03-11 US US16/297,910 patent/US10538542B2/en active Active
- 2019-03-11 TW TW108108048A patent/TWI741268B/en not_active IP Right Cessation
- 2019-03-12 ES ES19717149T patent/ES2923298T3/en active Active
- 2019-03-12 WO PCT/IB2019/052009 patent/WO2019175776A1/en active Application Filing
- 2019-03-12 CA CA3093631A patent/CA3093631C/en active Active
- 2019-03-12 MA MA052012A patent/MA52012A/en unknown
- 2019-03-12 BR BR112020018593-0A patent/BR112020018593A2/en not_active IP Right Cessation
- 2019-03-12 RU RU2020130048A patent/RU2020130048A/en unknown
- 2019-03-12 CR CR20200382A patent/CR20200382A/en unknown
- 2019-03-12 PE PE2020001412A patent/PE20210412A1/en unknown
- 2019-03-12 AU AU2019234043A patent/AU2019234043A1/en not_active Abandoned
- 2019-03-12 SG SG11202008102VA patent/SG11202008102VA/en unknown
- 2019-03-12 MX MX2020009587A patent/MX2020009587A/en unknown
- 2019-03-12 JP JP2020548916A patent/JP7266942B2/en active Active
- 2019-03-12 KR KR1020207029472A patent/KR20200131878A/en not_active Application Discontinuation
- 2019-03-12 CN CN201980019494.9A patent/CN111918871A/en active Pending
- 2019-03-12 EP EP19717149.9A patent/EP3765474B1/en active Active
- 2019-03-13 UY UY38145A patent/UY38145A/en unknown
- 2019-12-04 US US16/702,738 patent/US10968242B2/en active Active
-
2020
- 2020-08-25 DO DO2020000160A patent/DOP2020000160A/en unknown
- 2020-08-28 NI NI202000058A patent/NI202000058A/en unknown
- 2020-09-10 IL IL277278A patent/IL277278A/en unknown
- 2020-09-11 CL CL2020002352A patent/CL2020002352A1/en unknown
- 2020-09-12 PH PH12020551486A patent/PH12020551486A1/en unknown
- 2020-09-15 EC ECSENADI202057847A patent/ECSP20057847A/en unknown
-
2021
- 2021-03-03 US US17/190,924 patent/US20210230196A1/en not_active Abandoned
-
2023
- 2023-07-24 US US18/225,589 patent/US20230382932A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL277278A (en) | Cyclopentane-based modulators of sting (stimulator of interferon genes) | |
| IL276844A (en) | Agonists of stimulator of interferon genes sting | |
| ZA201904311B (en) | Cyclic dinucleotides as sting (stimulator of interferon genes) agonists | |
| IL272928A (en) | Cyclic di-nucleotides as stimulator of interferon genes modulators | |
| ZA201908496B (en) | Small molecule modulators of human sting | |
| HK1247089A1 (en) | Copositions and methods for activing "stimulator of interferon gene"-dependent signalling | |
| EP3585379A4 (en) | Cyclic dinucleotides as agonists of stimulator of interferon gene dependent signalling | |
| IL288868A (en) | Next-generation modulators of stimulator of interferon genes (sting) | |
| IL291650A (en) | Polyheterocyclic modulators of sting (stimulator of interferon genes) | |
| GB201709959D0 (en) | Small molecule modulators of human STING | |
| IL281492A (en) | Modulators of pnpla3 expression | |
| IL272373A (en) | Factor viii (fviii) gene therapy methods | |
| IL283967A (en) | Modulators of hsd17b13 expression | |
| EP3410996A4 (en) | Reproducible placement of abi electrodes | |
| IL279685A (en) | Gene therapy | |
| IL290772A (en) | Monocyclic agonists of stimulator of interferon genes sting | |
| EP3787693A4 (en) | Methods of gene therapy | |
| IL277847A (en) | Modulators of ezh2 expression | |
| IL274231A (en) | Modulators of enac expression | |
| IL290771A (en) | Bicyclic agonists of stimulator of interferon genes sting | |
| GB201802326D0 (en) | Gene therapy | |
| IL285333A (en) | Modulators of malat1 expression | |
| GB201810172D0 (en) | Azaheteocyclic small molecule modulators of human sting | |
| SG11202101042SA (en) | Gene therapy methods to control organ function | |
| EP3760209C0 (en) | Ischemic-lesion-site-specific gene therapy |